NEPENTHE
Cervical Pain
Hacettepe UniversitySmall moleculeN/AActive
D
30/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 15/ 100
- Competitive Position
- 95/ 100
Competitive context
2 Active assets in the Cervical Pain cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Clonidine Annette C. Toledano MD | Phase 2 | B |
Naltrexone Annette C. Toledano MD | Phase 2 | B |
NORADRENALINE TARTRATE IMPURITY C Universidad San Sebastián | N/A | D |
Plavix Universidad San Sebastián | N/A | D |
METAMIZOLE Hacettepe University | N/A | D |
View all 9 →
Same molecule, other indications
NEPENTHE is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →